Brain valve registry checks safety in 160 patients

NCT ID NCT05397106

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 160 people who have or will get a CODMAN CERTAS Plus valve, a device implanted in the brain to drain extra fluid. The main goal is to see if the valve is placed correctly and works without problems 30 days after surgery. Participants include children and adults with conditions like hydrocephalus, brain tumors, or stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CODMAN CERTAS Plus Programmable Valve (a surgically implanted device that helps drain excess fluid from the brain)
What this could lead to
If successful, this study will confirm that the valve is safe and works as intended for people with hydrocephalus.
What could go wrong
This is an observational registry, not a test of a new treatment. It only checks short-term device placement, not long-term benefits or risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AZ Delta - Roeselare

    Roeselare, Belgium

  • Canton Hospital St. Gallen

    Sankt Gallen, Switzerland

  • Freiburg University Hospital

    Freiburg im Breisgau, Germany

  • Heinrich Heine University, Dept of Neurosurgery, Universitätsklinik Düsseldorf

    Düsseldorf, 40225, Germany

  • Hospital12 de Octubre

    Madrid, Spain

  • Katharinenhospital - Neurochirurgische Klinik Stuttgart

    Stuttgart, Germany

  • Klinikum Dortmund Wirbelsäulenchirurgie

    Dortmund, Germany

  • University Hospital Leuven

    Leuven, Belgium

  • Universitätsklinikum Essen

    Essen, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.